Neurogene Inc. (NASDAQ: NGNE) Stock Information | RedChip

Neurogene Inc. (NASDAQ: NGNE) Listen to this Section


$34.84
-0.7800 ( -2.19% ) 45.2K

Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.

Market Data


Open


$34.84

Previous close


$35.62

Volume


45.2K

Market cap


$455.04M

Day range


$34.50 - $36.92

52 week range


$12.49 - $53.00

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
3 Insider transactions 2 Dec 26, 2023
4 Insider transactions 1 Dec 20, 2023
8-k 8K-related 41 Dec 19, 2023
8-k 8K-related 12 Dec 06, 2023
8-k 8K-related 13 Dec 04, 2023
10-q Quarterly Reports 51 Nov 14, 2023
4 Insider transactions 1 Oct 10, 2023
8-k 8K-related 16 Sep 22, 2023
4 Insider transactions 1 Aug 17, 2023
4 Insider transactions 1 Aug 14, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.